Personal information

Emails & domains

Verified email domains

Websites & social links

Myles Lewis - QMUL

Other IDs

Loop profile: 1709895
Scopus Author ID: 7404188045

Keywords

Systemic Lupus Erythematosus, Rheumatoid arthritis, Bioinformatics, Ubiquitination

Countries

United Kingdom

Activities

Collapse all

Employment (4)

Queen Mary University of London: London, GB

2023-08-01 to present | Professor (Precision Medicine & Rheumatology)
Employment
Source: Self-asserted source
Myles J Lewis

Queen Mary University of London: London, GB

2021-08-01 to 2023-08-01 | Clinical Reader (Experimental Medicine & Rheumatology)
Employment
Source: Self-asserted source
Myles J Lewis

Queen Mary University of London: London, GB

2014-02-14 to 2021-08-01 | Senior Clinical Lecturer (Experimental Medicine & Rheumatology)
Employment
Source: Self-asserted source
Myles J Lewis

King's College London: London, GB

2010-10-01 to 2014-02-14 | Senior Research Fellow (Immunogenetics)
Employment
Source: Self-asserted source
Myles J Lewis

Education and qualifications (3)

Imperial College London: London, London, GB

2005 to 2008 | PhD (Hammersmith Hospital)
Education
Source: Self-asserted source
Myles J Lewis

University of Oxford: Oxford, Oxfordshire, GB

1995 to 1998 | BM BCh (Medical School)
Education
Source: Self-asserted source
Myles J Lewis

University of Cambridge: Cambridge, Cambridgeshire, GB

1992 to 1995 | BA (Preclinical Medicine)
Education
Source: Self-asserted source
Myles J Lewis

Professional activities (2)

Royal College of Physicians: London, London, GB

2018-12-01 to present | Fellow
Membership
Source: Self-asserted source
Myles J Lewis

Academy of Medical Sciences: London, GB

2015-02 | Lancet prize for Clinician Scientist Fellows
Distinction
Source: Self-asserted source
Myles J Lewis

Funding (20)

Targeting cancer pain

2023-09 to 2028-09 | Grant
Cancer Research UK (London, GB)
Source: Self-asserted source
Myles J Lewis

Targeting nociplastic pain in arthritis

2021-09 to 2024-09 | Grant
Foundation for Research in Rheumatology (Kilchberg, CH)
Source: Self-asserted source
Myles J Lewis

Accelerating new treatments for refractory RA through targeting the FGF family

2021-08 to 2024-08 | Grant
Versus Arthritis (Chesterfield, GB)
Source: Self-asserted source
Myles J Lewis

Development and Validation of a Transcriptomic-Based Model for Classifying and Predicting Treatment Response in Rheumatoid Arthritis Patients (TRACT-RA)

2021-08 to 2023-08 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER:

MR/V012509/1
Source: Self-asserted source
Myles J Lewis

Evaluating treatment response mechanisms of Rituximab and Tocilizumab in Rheumatoid Arthritis in the R4RA randomised clinical trial

2021-04 to 2023-04 | Grant
National Institute for Health Research (Southampton, GB)
GRANT_NUMBER:

NIHR131575
Source: Self-asserted source
Myles J Lewis

Developing biomarkers for the inflammatory state of activated T cells in SLE

2020-12 to 2024-01 | Grant
Barts Charity (London, GB)
Source: Self-asserted source
Myles J Lewis

The role of ubiquitination in type I interferon production in SLE

2020-10 to 2024-01 | Grant
Barts charity (London, GB)
GRANT_NUMBER:

MRC0289
Source: Self-asserted source
Myles J Lewis

Genetic analysis of pro-inflammatory pathways in Rheumatoid Arthritis

2020-10 to 2023-10 | Award
Medical College of St Bartholomew's Hospital Trust (London, GB)
Source: Self-asserted source
Myles J Lewis

Identification of autoantigens in EGPA and severe asthma (IDEA)

2020-09 to 2022-10 | Grant
GlaxoSmithKline (London, GB)
Source: Self-asserted source
Myles J Lewis

The pathogenic role of interleukin-36 in Systemic Lupus Erythematosus

2020-07 to 2023-07 | Award
Versus Arthritis (Chesterfield, GB)
Source: Self-asserted source
Myles J Lewis

Genetic Analysis of Plasmablast Development in Autoimmunity

2018-12 to 2019-12 | Grant
Barts Charity (London, GB)
GRANT_NUMBER:

MGU0452
Source: Self-asserted source
Myles J Lewis

Therapeutic Effect of Dimethyl Fumarate on ectopic germinal centres in a model of sialadenitis

2018-01 to 2019-04 | Grant
British Sjögren's Syndrome Association (London, GB)
Source: Self-asserted source
Myles J Lewis

Barts Health ECAM RCF support

2017-04 to 2018-04 | Grant
Barts Health ECAM RCF (London, GB)
Source: Self-asserted source
Myles J Lewis

Barts Health ECAM RCF support

2016-04 to 2017-04 | Grant
Barts Health ECAM RCF (London, GB)
Source: Self-asserted source
Myles J Lewis

Barts Health ECAM RCF support

2015-04 to 2016-04 | Grant
Barts Health ECAM RCF (London, GB)
Source: Self-asserted source
Myles J Lewis

CRN RCF support

2014-04 to 2015-04 | Grant
NIHR North Thames Clinical Research Network (London, GB)
Source: Self-asserted source
Myles J Lewis

The role of ubiquitination in SLE

2013-10 to 2014-04 | Grant
Isaac Schapera trust (London, GB)
Source: Self-asserted source
Myles J Lewis

Genetically-determined ubiquitination in autoimmunity

2011-11 to 2015-02 | Award
Arthritis Research UK (Chesterfield, GB)
GRANT_NUMBER:

19361
Source: Self-asserted source
Myles J Lewis

Graham Hughes Fellowship

2010-10 to 2011-12 | Grant
St Thomas Lupus charity (London, GB)
Source: Self-asserted source
Myles J Lewis

The effects of autoimmunity on atherosclerosis in a novel mouse model of SLE

2005 to 2008 | Award
Wellcome Trust (London, GB)
GRANT_NUMBER:

077045
Source: Self-asserted source
Myles J Lewis

Peer review (2 reviews for 2 publications/grants)

Review activity for Journal of translational medicine. (1)
Review activity for Nature immunology. (1)
How many people are using ORCID?